The aim of our study was to assess the clinical significance of-174G/C Il-6 gene
polymorphism and Il-6 serum level in patients with pancreatic adenocarcinoma (PA) and …

IL-6 is a pleiotropic cytokine with still controversial role in tumorigenesis of different cancer
types. Its promoter SNP-174 C/G is associated with increased IL-6 transcription and in some …

Purpose: Experimental data suggest that interleukin 6 (IL-6) plays an important role in the
development and progression of metastasis from colorectal cancer (CRC), and− 174 G> C …

Purpose: It has been suggested that interleukin-6 (IL-6) is a prognostic indicator for survival
in patients with gastric carcinoma, but this has not been proved using survival analysis. In …

Objective: To investigate whether interleukin-6 (IL-6) polymorphisms could be associated
with the occurrence of hepatocellular carcinoma (HCC) in patients with liver cirrhosis and …

Epidemiological and experimental data demonstrate, that inflammation contributes
significantly to pancreatic carcinogenesis. IL1β, a pleiotropic cytokine produced by …

AIM: To investigate the value of interleukin-8 (IL-8), a pro-inflammatory chemokine, in
predicting the prognosis of pancreatic cancer. METHODS: Expression of IL-8 and its …

The vast majority of pancreatic cancer patients have advanced disease at the time of
diagnosis and they eventually become so emaciated that death primarily occurs from cancer …

Abstract Background and Aim: Interleukin (IL)‐18 level and association of its two promoter
gene polymorphisms at− 607C/A and− 137G/C positions were investigated in Iranian …

Abstract Interleukin-6 (IL-6) is a pleiotropic cytokine which is expressed in many
inflammatory cells in response to different types of stimuli, regulating a number of biological …